Stock INMD INMODE LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials InMode Ltd.

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
17.14 USD +0.71% Intraday chart for InMode Ltd. -1.55% -22.93%
Apr. 12 Barclays Adjusts Price Target on InMode to $33 From $34, Maintains Overweight Rating MT
Apr. 09 Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,273 1,691 5,391 2,966 1,851 1,450 - -
Enterprise Value (EV) 1 1,080 1,430 4,975 2,966 1,109 439 178 -99.59
P/E ratio 24.5 x 26.7 x 36.8 x 18.9 x 9.67 x 7.42 x 6.88 x 6.39 x
Yield - - - - - - - -
Capitalization / Revenue 8.14 x 8.2 x 15.1 x 6.53 x 3.76 x 2.95 x 2.72 x 2.52 x
EV / Revenue 6.9 x 6.94 x 13.9 x 6.53 x 2.25 x 0.89 x 0.33 x -0.17 x
EV / EBITDA 18 x 16.6 x 27.8 x 13.3 x 5.05 x 2.06 x 0.77 x -0.4 x
EV / FCF 17.6 x 18.2 x 28.6 x 16.5 x 6.3 x 2.01 x 0.8 x -
FCF Yield 5.7% 5.51% 3.5% 6.07% 15.9% 49.8% 125% -
Price to Book 7.3 x 7.06 x 14.1 x - 2.43 x 1.39 x 1.11 x 0.91 x
Nbr of stocks (in thousands) 64,947 71,220 76,382 83,081 83,232 84,619 - -
Reference price 2 19.60 23.74 70.58 35.70 22.24 17.14 17.14 17.14
Announcement Date 2/18/20 2/10/21 2/10/22 2/14/23 2/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 156.4 206.1 357.6 454.3 492 491.9 534.2 574.8
EBITDA 1 59.92 86.1 179.2 223 219.9 212.9 232.6 248.2
EBIT 1 59.62 85.69 178.6 222.3 219.3 207.6 227.2 241.5
Operating Margin 38.13% 41.57% 49.96% 48.94% 44.56% 42.2% 42.53% 42.02%
Earnings before Tax (EBT) 1 62.04 76.13 168 201.5 217.3 222.2 244.6 271.1
Net income 1 61.14 75.03 165 161.5 197.9 198.6 216.5 234.7
Net margin 39.11% 36.4% 46.14% 35.56% 40.22% 40.36% 40.53% 40.83%
EPS 2 0.8000 0.8900 1.920 1.890 2.300 2.309 2.492 2.682
Free Cash Flow 1 61.51 78.76 173.9 180 176.1 218.8 222.6 -
FCF margin 39.34% 38.21% 48.65% 39.62% 35.79% 44.48% 41.67% -
FCF Conversion (EBITDA) 102.66% 91.48% 97.09% 80.72% 80.1% 102.77% 95.69% -
FCF Conversion (Net income) 100.6% 104.97% 105.44% 111.44% 88.99% 110.18% 102.82% -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/18/20 2/10/21 2/10/22 2/14/23 2/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 94.18 110.5 85.92 113.5 121.2 133.6 106.1 136.1 123.1 126.8 91.37 124.9 133.4 142.2 111.4
EBITDA 1 48.35 56.62 38.24 55.71 61.77 67.26 45.39 63.7 53.1 57.69 35.64 54.32 59.35 63.53 45.18
EBIT 1 48.21 56.48 38.1 55.56 61.6 67.05 45.21 63.51 52.97 57.57 34.34 53.02 58.02 62.22 45.01
Operating Margin 51.19% 51.09% 44.35% 48.93% 50.81% 50.2% 42.62% 46.67% 43.03% 45.41% 37.58% 42.44% 43.49% 43.75% 40.41%
Earnings before Tax (EBT) 1 44.95 54.27 35.39 48.28 53.93 63.86 44.29 61.45 51.36 60.16 35.89 56.93 62.53 66.89 40.78
Net income 1 44.72 52.68 30.98 44.05 48.79 37.71 40.5 55.73 46.52 55.16 33.33 50.5 55.15 59.59 41.64
Net margin 47.48% 47.66% 36.05% 38.79% 40.24% 28.23% 38.19% 40.95% 37.79% 43.51% 36.48% 40.43% 41.34% 41.9% 37.39%
EPS 2 0.5200 0.6100 0.3600 0.5200 0.5800 0.4400 0.4700 0.6500 0.5400 0.6400 0.3914 0.5885 0.6398 0.6926 0.5077
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 10/26/21 2/10/22 5/2/22 7/28/22 10/27/22 2/14/23 5/2/23 7/27/23 11/2/23 2/13/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 193 261 416 - 742 1,011 1,272 1,550
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 61.5 78.8 174 180 176 219 223 -
ROE (net income / shareholders' equity) 55.8% 34.9% 49.3% 33.3% 29.5% 22.9% 19.8% 17.1%
ROA (Net income/ Total Assets) 40.8% 29.2% 34.5% 28.8% 26.3% 17.9% 16% -
Assets 1 149.7 257.1 478.5 561.5 753.8 1,109 1,353 -
Book Value Per Share 2 2.680 3.360 5.010 - 9.160 12.30 15.40 18.70
Cash Flow per Share 2 0.8200 0.9400 2.030 2.130 2.060 2.530 2.560 -
Capex 1 0.69 0.46 0.94 1.58 0.71 0.73 1.29 0.73
Capex / Sales 0.44% 0.22% 0.26% 0.35% 0.14% 0.15% 0.24% 0.13%
Announcement Date 2/18/20 2/10/21 2/10/22 2/14/23 2/13/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
17.14 USD
Average target price
27.6 USD
Spread / Average Target
+61.03%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
INMODE LTD. Stock InMode Ltd.
-22.93% 1.45B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. INMD Stock
  4. Financials InMode Ltd.